Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:26 PM
Ignite Modification Date: 2025-12-25 @ 2:19 PM
NCT ID: NCT04986566
Description: Since this is not a drug trial, adverse events were not recorded.
Frequency Threshold: 0
Time Frame: This is an intervention trial lasting three months post-treatment, with no blood draws, procedures, or other invasive assessments. Since this is not a drug trial, patients were not monitored for specific adverse events. However, one patient died prior to study participation. Each participant was monitored for mortality during the three-month post-discharge period.
Study: NCT04986566
Study Brief: Perioperative Telemonitoring to Optimize Cancer Care and Outcomes
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Arm I (Telemonitoring) Patients wear a Vivofit 4 daily for 30 days after hospital discharge for steps monitoring, and complete questionnaires over 5-7 minutes about symptoms and quality of life using the Aetonixx app up to 7 days before surgery, before being discharged from the hospital after surgery, and on days 2, 7, 14, 30 after discharge. Patients also complete pulse oximetry, temperature, blood pressure, heart rate, and weight assessment using at-home monitoring devices before surgery, then on days 2, 7, 14, 30 after discharge. Patients assessments are monitored by the surgical team in real-time to identify outcome trends, including onset, worsening/improving measures, and sporadic versus consistent measures. Best Practice: Use standard reporting procedures Health Education: Use Aetonixx app Medical Device Usage and Evaluation: Wear Vivofit 4 Quality-of-Life Assessment: Complete questionnaires 0 None 0 0 0 0 View
Arm II (Enhanced Usual Care) Patients wear a Vivofit 4 for daily steps monitoring, and complete questionnaires over 5-7 minutes about symptoms and quality of life using the Aetonixx app up to 7 days before surgery, before being discharged from the hospital after surgery, and on days 2, 7, 14, 30 after discharge. Patients also complete pulse oximetry, temperature, blood pressure, heart rate, and weight assessment using at-home monitoring devices before surgery, then on days 2, 7, 14, 30 after discharge. Patients use standard procedures for reporting problems. Best Practice: Use standard reporting procedures Health Education: Use Aetonixx app Medical Device Usage and Evaluation: Wear Vivofit 4 Quality-of-Life Assessment: Complete questionnaires 1 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):